{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:13:57Z","timestamp":1793117637028,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.pcad.2021.11.003","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T06:25:47Z","timestamp":1637130347000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Transcatheter aortic valve replacement (TAVR): Recent updates"],"prefix":"10.1016","volume":"69","author":[{"given":"Marisa","family":"Avvedimento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert H.L.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pcad.2021.11.003_bb0005","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.pcad.2021.11.003_bb0010","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.pcad.2021.11.003_bb0015","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.pcad.2021.11.003_bb0020","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.pcad.2021.11.003_bb0025","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.pcad.2021.11.003_bb0030","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.pcad.2021.11.003_bb0035","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.jacc.2014.02.556","article-title":"Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery","volume":"63","author":"Popma","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.pcad.2021.11.003_bb0040","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.pcad.2021.11.003_bb0045","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.pcad.2021.11.003_bb0050","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2020.12.052","article-title":"Outcomes 2 years after transcatheter aortic valve replacement in patients at low surgical risk","volume":"77","author":"Leon","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"10.1016\/j.pcad.2021.11.003_bb0055","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/eurheartj\/ehz275","article-title":"Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis","volume":"40","author":"Siontis","year":"2019","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.pcad.2021.11.003_bb0060","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1001\/jama.2014.3316","article-title":"Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial","volume":"311","author":"Abdel-Wahab","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pcad.2021.11.003_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/jama.2017.19132","article-title":"Effect of mechanically expanded vs self-expanding transcatheter aortic valve replacement on mortality and major adverse clinical events in high-risk patients with aortic stenosis: the REPRISE III randomized clinical trial","volume":"319","author":"Feldman","year":"2018","journal-title":"JAMA"},{"issue":"10209","key":"10.1016\/j.pcad.2021.11.003_bb0070","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0140-6736(19)32220-2","article-title":"Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial","volume":"394","author":"Lanz","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"25","key":"10.1016\/j.pcad.2021.11.003_bb0075","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/CIRCULATIONAHA.120.051547","article-title":"Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: SCOPE 2 randomized clinical trial","volume":"142","author":"Tamburino","year":"2020","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.pcad.2021.11.003_bb0080","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"VARC-3 WRITING COMMITTEE","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2021.11.003_bb0085","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.117.030729","article-title":"Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves","volume":"137","author":"Dvir","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2021.11.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab375","article-title":"Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement","author":"J\u00f8rgensen","year":"2021","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.pcad.2021.11.003_bb0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jcin.2020.02.008","article-title":"Transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis","volume":"13","author":"Waksman","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.pcad.2021.11.003_bb0100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2021.11.003_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.athoracsur.2014.06.050","article-title":"Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients","volume":"99","author":"Thourani","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"10.1016\/j.pcad.2021.11.003_bb0110","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.amjcard.2020.02.005","article-title":"Valve-in-valve transcatheter implantation versus redo surgical aortic valve replacement","volume":"125","author":"Malik","year":"2020","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2021.11.003_bb0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2014.7246","article-title":"Transcatheter aortic valve implantation in failed bioprosthetic surgical valves","volume":"312","author":"Dvir","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pcad.2021.11.003_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019512","article-title":"Meta-analysis of stroke and mortality rates in patients undergoing valve-in-valve transcatheter aortic valve replacement","volume":"10","author":"Macherey","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"21","key":"10.1016\/j.pcad.2021.11.003_bb0125","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.jacc.2019.03.483","article-title":"3-year outcomes after valve-in-valve transcatheter aortic valve replacement for degenerated bioprostheses: the PARTNER 2 registry","volume":"73","author":"Webb","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"29","key":"10.1016\/j.pcad.2021.11.003_bb0130","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/eurheartj\/ehaa544","article-title":"Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves","volume":"41","author":"Bleiziffer","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.pcad.2021.11.003_bb0135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0002-9149(70)90761-7","article-title":"The congenitally bicuspid aortic valve. A study of 85 autopsy cases","volume":"26","author":"Roberts","year":"1970","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.pcad.2021.11.003_bb0140","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.300.11.1317","article-title":"Outcomes in adults with bicuspid aortic valves","volume":"300","author":"Tzemos","year":"2008","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.pcad.2021.11.003_bb0145","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jamacardio.2017.1685","article-title":"Trends and outcomes of off-label use of transcatheter aortic valve replacement: insights from the NCDR STS\/ACC TVT registry","volume":"2","author":"Hira","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"22","key":"10.1016\/j.pcad.2021.11.003_bb0150","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jacc.2014.09.039","article-title":"Transcatheter aortic valve replacement in bicuspid aortic valve disease","volume":"64","author":"Mylotte","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.pcad.2021.11.003_bb0155","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.jacc.2017.03.017","article-title":"Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis","volume":"69","author":"Yoon","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.pcad.2021.11.003_bb0160","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1001\/jama.2019.7108","article-title":"Association between transcatheter aortic valve replacement for bicuspid vs tricuspid aortic stenosis and mortality or stroke","volume":"321","author":"Makkar","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.pcad.2021.11.003_bb0165","first-page":"1","article-title":"Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap","volume":"13","author":"Forrest","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.pcad.2021.11.003_bb0170","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jacc.2020.07.005","article-title":"Bicuspid aortic valve morphology and outcomes after transcatheter aortic valve replacement","volume":"76","author":"Yoon","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2021.11.003_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008714","article-title":"Balloon versus self-expandable valve for the treatment of bicuspid aortic valve stenosis: insights from the BEAT international collaborative registrys","volume":"13","author":"Mangieri","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.003_bb0180","series-title":"Primary Results from the Evolut Low Risk Bicuspid Study. ACC20\/WCC","author":"Ramlawi","year":"2020"},{"key":"10.1016\/j.pcad.2021.11.003_bb0185","series-title":"The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. TVT","author":"Williams","year":"2021"},{"issue":"23","key":"10.1016\/j.pcad.2021.11.003_bb0190","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2019.7525","article-title":"Association between transcatheter aortic valve replacement and early Postprocedural stroke","volume":"321","author":"Huded","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.pcad.2021.11.003_bb0195","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.amjcard.2016.07.011","article-title":"Meta-analysis of perioperative stroke and mortality in transcatheter aortic valve implantation","volume":"118","author":"Muralidharan","year":"2016","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2021.11.003_bb0200","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/CIRCULATIONAHA.109.855866","article-title":"Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study","volume":"121","author":"Kahlert","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2021.11.003_bb0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacc.2010.07.036","article-title":"Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches","volume":"57","author":"Rod\u00e9s-Cabau","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.pcad.2021.11.003_bb0210","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jcin.2010.09.008","article-title":"Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging","volume":"3","author":"Arnold","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.pcad.2021.11.003_bb0215","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4244\/EIJV12I4A84","article-title":"Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial","volume":"12","author":"Van Mieghem","year":"2016","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.pcad.2021.11.003_bb0220","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jama.2016.10302","article-title":"Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial","volume":"316","author":"Haussig","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pcad.2021.11.003_bb0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jacc.2016.10.023","article-title":"Protection against cerebral embolism during transcatheter aortic valve replacement","volume":"69","author":"Kapadia","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"31","key":"10.1016\/j.pcad.2021.11.003_bb0230","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehv191","article-title":"A prospective randomized evaluation of the TriGuardTM HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial","volume":"36","author":"Lansky","year":"2015","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.pcad.2021.11.003_bb0235","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.athoracsur.2015.03.119","article-title":"Intraaortic protection from embolization in patients undergoing transaortic transcatheter aortic valve implantation","volume":"100","author":"Wendt","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.pcad.2021.11.003_bb0240","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jacc.2016.12.002","article-title":"Cerebral embolic protection during TAVR: a clinical event meta-analysis","volume":"69","author":"Giustino","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2021.11.003_bb0245","article-title":"Cerebral embolic protection during transcatheter aortic valve replacement","author":"Yashima","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"issue":"23","key":"10.1016\/j.pcad.2021.11.003_bb0250","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1161\/CIRCULATIONAHA.120.052874","article-title":"Cerebral embolic protection and outcomes of transcatheter aortic valve replacement: results from the transcatheter valve therapy registry","volume":"143","author":"Butala","year":"2021","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.pcad.2021.11.003_bb0255","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1161\/CIRCULATIONAHA.112.110981","article-title":"Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation","volume":"126","author":"Nombela-Franco","year":"2012","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.pcad.2021.11.003_bb0260","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.jacc.2018.08.2146","article-title":"5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients","volume":"72","author":"Gleason","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2021.11.003_bb0265","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/eurheartj\/ehu384","article-title":"Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes","volume":"36","author":"Kodali","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2021.11.003_bb0270","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-20-01206","article-title":"Long-term outcomes of catheter-based intervention for clinically significant paravalvular leak","author":"Perl","year":"2021","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.pcad.2021.11.003_bb0275","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcin.2019.08.035","article-title":"Three generations of self-expanding transcatheter aortic valves: a report from the STS\/ACC TVT registry","volume":"13","author":"Forrest","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.pcad.2021.11.003_bb0280","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.4244\/EIJ-D-19-00541","article-title":"In-hospital and thirty-day outcomes of the SAPIEN 3 ultra balloon-expandable transcatheter aortic valve: the S3U registry","volume":"15","author":"Saia","year":"2020","journal-title":"EuroIntervention"},{"issue":"8","key":"10.1016\/j.pcad.2021.11.003_bb0285","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.amjcard.2020.01.008","article-title":"Novel anatomic predictors of new persistent left bundle branch block after evolut transcatheter aortic valve implantation","volume":"125","author":"Zaid","year":"2020","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2021.11.003_bb0290","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jcin.2019.10.053","article-title":"Novel predictors of new persistent left bundle branch block after SAPIEN 3 transcatheter aortic valve replacement","volume":"13","author":"Zaid","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.pcad.2021.11.003_bb0295","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacc.2014.04.033","article-title":"Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis","volume":"64","author":"Siontis","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.pcad.2021.11.003_bb0300","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jcin.2018.03.018","article-title":"\u201cCusp-overlap\u201d view simplifies fluoroscopy-guided implantation of self-expanding valve in transcatheter aortic valve replacement","volume":"11","author":"Tang","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2021.11.003_bb0305","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9991528","article-title":"Impact of cusp-overlap view for TAVR with self-expandable valves on 30-day conduction disturbances","volume":"2021","author":"Mendiz","year":"2021","journal-title":"J Interv Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2021.11.003_bb0310","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009407","article-title":"Systematic approach to high implantation of SAPIEN-3 valve achieves a lower rate of conduction abnormalities including pacemaker implantation","volume":"14","author":"Sammour","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.pcad.2021.11.003_bb0315","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jacc.2019.07.014","article-title":"Management of conduction disturbances associated with transcatheter aortic valve replacement: JACC scientific expert panel","volume":"74","author":"Rod\u00e9s-Cabau","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2021.11.003_bb0320","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jcin.2015.05.010","article-title":"Inverse relationship between membranous septal length and the risk of atrioventricular block in patients undergoing transcatheter aortic valve implantation","volume":"8","author":"Hamdan","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.pcad.2021.11.003_bb0325","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.jcin.2019.05.056","article-title":"Minimizing permanent pacemaker following repositionable self-expanding transcatheter aortic valve replacement","volume":"12","author":"Jilaihawi","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.pcad.2021.11.003_bb0330","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.4244\/EIJV12I9A192","article-title":"Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) pacemaker substudy","volume":"12","author":"Giustino","year":"2016","journal-title":"EuroIntervention"},{"issue":"12","key":"10.1016\/j.pcad.2021.11.003_bb0335","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jacc.2018.01.057","article-title":"Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement","volume":"71","author":"Yudi","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.pcad.2021.11.003_bb0340","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007263","article-title":"Transcatheter valve neo-commissural overlap with coronary orifices after transcatheter aortic valve replacement","volume":"11","author":"Tang","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.pcad.2021.11.003_bb0345","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jcin.2020.01.202","article-title":"Feasibility of coronary access and aortic valve reintervention in low-risk TAVR patients","volume":"13","author":"Rogers","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.pcad.2021.11.003_bb0350","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcin.2020.10.031","article-title":"Unplanned percutaneous coronary revascularization after TAVR: a multicenter international registry","volume":"14","author":"Stefanini","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"10.1016\/j.pcad.2021.11.003_bb0355","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jcin.2020.07.006","article-title":"Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study","volume":"13","author":"Barbanti","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.pcad.2021.11.003_bb0360","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008044","article-title":"Impact of initial evolut transcatheter aortic valve replacement deployment orientation on final valve orientation and coronary reaccess","volume":"12","author":"Tang","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.pcad.2021.11.003_bb0365","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/eurheartj\/ehx455","article-title":"Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry","volume":"39","author":"Ribeiro","year":"2018","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.pcad.2021.11.003_bb0370","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jcin.2020.01.227","article-title":"Chimney stenting for coronary occlusion during TAVR: insights from the chimney registry","volume":"13","author":"Mercanti","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.pcad.2021.11.003_bb0375","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jcin.2021.02.035","article-title":"Preventing coronary obstruction during transcatheter aortic valve replacement: results from the multicenter international BASILICA registry","volume":"14","author":"Khan","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.pcad.2021.11.003_bb0380","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jcin.2019.11.024","article-title":"Coronary protection to prevent coronary obstruction during TAVR: a multicenter international registry","volume":"13","author":"Palmerini","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.pcad.2021.11.003_bb0385","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jcin.2021.05.007","article-title":"Feasibility of coronary access in patients with acute coronary syndrome and previous TAVR","volume":"14","author":"Kim","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"19","key":"10.1016\/j.pcad.2021.11.003_bb0390","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.jacc.2020.03.022","article-title":"Bioprosthetic aortic valve leaflet thickening in the evolut low risk sub-study","volume":"75","author":"Blanke","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.pcad.2021.11.003_bb0395","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.jacc.2020.04.043","article-title":"Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy","volume":"75","author":"Makkar","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2021.11.003_bb0400","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.pcad.2021.11.003_bb0405","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.pcad.2021.11.003_bb0410","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.pcad.2021.11.003_bb0415","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jcin.2021.06.020","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement","volume":"14","author":"Capodanno","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"10.1016\/j.pcad.2021.11.003_bb0420","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehab196","article-title":"Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collabor","volume":"42","author":"Ten Berg","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.pcad.2021.11.003_bb0425","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezs533","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document (varc-2)","volume":"42","author":"Kappetein","year":"2012","journal-title":"Eur J Cardio-thoracic Surg"},{"issue":"28","key":"10.1016\/j.pcad.2021.11.003_bb0430","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/eurheartj\/ehy107","article-title":"Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections","volume":"39","author":"Durko","year":"2018","journal-title":"Eur Heart J"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:20:14Z","timestamp":1758500414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062021001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":86,"alternative-id":["S0033062021001225"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2021.11.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcatheter aortic valve replacement (TAVR): Recent updates","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2021.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}